CNB Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-89
| Closed | -$7.59K | – | 527 |
|
|
2025
Q4 | $7.59K | Hold |
89
| – | – | ﹤0.01% | 425 |
|
|
2025
Q3 | $6.92K | Hold |
89
| – | – | ﹤0.01% | 426 |
|
|
2025
Q2 | $6.96K | Hold |
89
| – | – | ﹤0.01% | 408 |
|
|
2025
Q1 | $6.45K | Hold |
89
| – | – | ﹤0.01% | 398 |
|
|
2024
Q4 | $6.59K | Sell |
89
-898
| -91% | -$62.9K | ﹤0.01% | 414 |
|
|
2024
Q3 | $65.1K | Sell |
987
-1,071
| -52% | -$77.8K | 0.03% | 231 |
|
|
2024
Q2 | $190K | Sell |
2,058
-257
| -11% | -$22.8K | 0.09% | 160 |
|
|
2024
Q1 | $221K | Sell |
2,315
-152
| -6% | -$12.8K | 0.11% | 151 |
|
|
2023
Q4 | $188K | Sell |
2,467
-488
| -17% | -$34K | 0.1% | 158 |
|
|
2023
Q3 | $205K | Sell |
2,955
-2,209
| -43% | -$178K | 0.12% | 153 |
|
|
2023
Q2 | $487K | Sell |
5,164
-99
| -2% | -$8.61K | 0.29% | 92 |
|
|
2023
Q1 | $435K | Buy |
5,263
+380
| +8% | +$29.9K | 0.27% | 95 |
|
|
2022
Q4 | $364K | Buy |
4,883
+422
| +9% | +$32.5K | 0.23% | 103 |
|
|
2022
Q3 | $368K | Buy |
4,461
+334
| +8% | +$32.1K | 0.25% | 94 |
|
|
2022
Q2 | $392K | Buy |
4,127
+150
| +4% | +$15.5K | 0.25% | 95 |
|
|
2022
Q1 | $469K | Sell |
3,977
-179
| -4% | -$20.1K | 0.26% | 96 |
|
|
2021
Q4 | $538K | Buy |
4,156
+247
| +6% | +$28.8K | 0.29% | 93 |
|
|
2021
Q3 | $442K | Buy |
3,909
+268
| +7% | +$30.6K | 0.27% | 98 |
|
|
2021
Q2 | $376K | Buy |
3,641
+160
| +5% | +$15.1K | 0.24% | 107 |
|
|
2021
Q1 | $291K | Buy |
3,481
+543
| +18% | +$45.9K | 0.2% | 113 |
|
|
2020
Q4 | $268K | Buy |
2,938
+407
| +16% | +$33.8K | 0.2% | 109 |
|
|
2020
Q3 | $202K | Sell |
2,531
-261
| -9% | -$20.4K | 0.17% | 114 |
|
|
2020
Q2 | $193K | Buy |
2,792
+149
| +6% | +$10.6K | 0.17% | 116 |
|
|
2020
Q1 | $166K | Buy |
2,643
+258
| +11% | +$18.6K | 0.18% | 129 |
|
|
2019
Q4 | $185K | Buy |
2,385
+48
| +2% | +$3.75K | 0.16% | 145 |
|
|
2019
Q3 | $171K | Buy |
2,337
+1,770
| +312% | +$124K | 0.16% | 143 |
|
|
2019
Q2 | $35K | Buy |
+567
| New | +$34.3K | 0.03% | 249 |
|
|
2018
Q1 | – | Sell |
-282
| Closed | -$11K | – | 314 |
|
|
2017
Q4 | $11K | Buy |
+282
| New | +$10.3K | 0.01% | 234 |
|
Other funds holding EW
CNB Bank's EW Position: Q1 2026 in Review
CNB Bank sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 89 shares — an estimated $7.59K sold.
CNB Bank first reported a position in EW in Q4 2017 and held it in 28 quarters. The position peaked at $538K in Q4 2021. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- CNB Bank reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
- CNB Bank sold 89 Edwards Lifesciences shares in Q1 2026, an estimated $7.59K.
- CNB Bank first reported a position in Edwards Lifesciences in Q4 2017 and held it in 28 quarters.
- CNB Bank's Edwards Lifesciences position peaked at $538K in Q4 2021.
- 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.